Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidekazu Shirota

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 26, 2022
[Cooperative Tasks among Cancer Genome Medicine Facilities]Hidekazu Shirota
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 24, 2020
[The Role of Core Hospital of Cancer Genomic Medicine and Regional Cooperation]Hidekazu Shirota, Keigo Komine
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[Interinstitutional Collaboration for Molecular Tumor Boards]Keigo Komine, Hidekazu Shirota
Cancer Immunology, Immunotherapy : CII|February 15, 2011
CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunityHidekazu Shirota, Dennis M Klinman
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
TLR-9 agonist immunostimulatory sequence adjuvants linked to cancer antigensHidekazu Shirota, Dennis M Klinman
Expert Review of Vaccines|December 7, 2013
Recent progress concerning CpG DNA and its use as a vaccine adjuvantHidekazu Shirota, Dennis M Klinman
Oncoimmunology|August 31, 2012
Effect of CpG ODN on monocytic myeloid derived suppressor cellsHidekazu Shirota, Dennis M Klinman
Vaccines|September 8, 2015
CpG Oligonucleotides as Cancer Vaccine AdjuvantsHidekazu Shirota, Debra Tross, Dennis M Klinman
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cellsYuko Shirota, Hidekazu Shirota, Dennis M Klinman
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signalingHidekazu Shirota, Mayda Gursel, Dennis M Klinman
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 26, 2022
[Cooperative Tasks among Cancer Genome Medicine Facilities]Hidekazu Shirota
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 24, 2020
[The Role of Core Hospital of Cancer Genomic Medicine and Regional Cooperation]Hidekazu Shirota, Keigo Komine
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[Interinstitutional Collaboration for Molecular Tumor Boards]Keigo Komine, Hidekazu Shirota
Cancer Immunology, Immunotherapy : CII|February 15, 2011
CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunityHidekazu Shirota, Dennis M Klinman
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
TLR-9 agonist immunostimulatory sequence adjuvants linked to cancer antigensHidekazu Shirota, Dennis M Klinman
Expert Review of Vaccines|December 7, 2013
Recent progress concerning CpG DNA and its use as a vaccine adjuvantHidekazu Shirota, Dennis M Klinman
Oncoimmunology|August 31, 2012
Effect of CpG ODN on monocytic myeloid derived suppressor cellsHidekazu Shirota, Dennis M Klinman
Vaccines|September 8, 2015
CpG Oligonucleotides as Cancer Vaccine AdjuvantsHidekazu Shirota, Debra Tross, Dennis M Klinman
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cellsYuko Shirota, Hidekazu Shirota, Dennis M Klinman
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signalingHidekazu Shirota, Mayda Gursel, Dennis M Klinman
Pageof 9